AI Article Synopsis

  • Hemophagocytic lymphohistiocytosis (HLH) is commonly linked with autoimmune diseases like systemic juvenile idiopathic arthritis and lupus, but this case is notable as it involves HLH with dermatomyositis and a rare complication of leukoencephalopathy.
  • A 17-year-old male with dermatomyositis and HLH experienced severe symptoms, leading to the discovery of brain lesions diagnosed as leukoencephalopathy, which were unresponsive to initial steroid treatments.
  • Treatment with a modified HLH-2004 protocol including etoposide successfully resolved the brain lesions, indicating that aggressive treatment may be crucial for HLH patients with central nervous system involvement, potentially considering bone marrow transplantation.

Article Abstract

Background: Hemophagocytic lymphohistiocytosis associated with autoimmune diseases is seen in patients with systemic juvenile idiopathic arthritis, adult-onset Still's disease, and systemic lupus erythematosus, whereas it is rarely seen in patients with dermatomyositis. In addition, central nervous system involvement with dermatomyositis is rare. To the best of our knowledge, this is the first case of hemophagocytic lymphohistiocytosis complicated by leukoencephalopathy in a patient with dermatomyositis accompanied with peripheral T-cell lymphoma.

Case Presentation: A 17-year-old Asian male adolescent with dermatomyositis and hemophagocytic lymphohistiocytosis that were controlled with corticosteroid therapy presented to our hospital with high fever and altered consciousness. Brain magnetic resonance imaging revealed multiple cerebral lesions. We diagnosed the central nervous system lesions as leukoencephalopathy secondary to dermatomyositis and hemophagocytic lymphohistiocytosis. Because corticosteroid and cyclophosphamide pulse therapy was ineffective, he was treated with a modified hemophagocytic lymphohistiocytosis-2004 protocol, which resulted in the disappearance of the lesions of his central nervous system.

Conclusions: Our findings suggest that the hemophagocytic lymphohistiocytosis-2004 protocol including etoposide should be initiated immediately in patients with hemophagocytic lymphohistiocytosis who respond poorly to treatment for the underlying disease. Moreover, irrespective of the underlying disease, patients with hemophagocytic lymphohistiocytosis with central nervous system lesions might require bone marrow transplantation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969676PMC
http://dx.doi.org/10.1186/s13256-016-0986-4DOI Listing

Publication Analysis

Top Keywords

hemophagocytic lymphohistiocytosis
28
central nervous
16
nervous system
12
hemophagocytic
9
leukoencephalopathy patient
8
patient dermatomyositis
8
dermatomyositis accompanied
8
accompanied peripheral
8
peripheral t-cell
8
dermatomyositis hemophagocytic
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!